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Peroxynitrite-induced poly(ADP-ribose) polymerase
activation has been implicated in the pathogenesis of
various in¯ammatory conditions. Here we have
investigated whether peroxynitrite and poly(ADP-
ribose) polymerase may play a role in the patho-
physiology of the elicitation phase of contact hyper-
sensitivity. We have detected nitrotyrosine, DNA
breakage, and poly(ADP-ribose) polymerase acti-
vation in the epidermis of mice in an oxazolone-
induced contact hypersensitivity model. As tyrosine
nitration is mostly mediated by peroxynitrite, a
nitric-oxide-derived cytotoxic oxidant capable of
causing DNA breakage, we have applied peroxynitrite
directly on mouse skin and showed poly(ADP-ribose)
polymerase activation in keratinocytes and in some
scattered dermal cells. We have also investigated the
cellular effects of peroxynitrite in HaCaT cells, a
human keratinocyte cell line. We found that peroxy-
nitrite inhibited cell proliferation and at higher con-
centrations also caused cytotoxicity. Peroxynitrite
activates poly(ADP-ribose) polymerase in HaCaT
cells and poly(ADP-ribose) polymerase activation
contributes to peroxynitrite-induced cytotoxicity, as
indicated by the cytoprotective effect of the
poly(ADP-ribose) polymerase inhibitor 3-aminoben-
zamide. The cytoprotective effect of 3-aminobenza-
mide cannot be attributed to inhibition of apoptosis,
as apoptotic parameters (caspase activation and DNA
fragmentation) were not reduced in the presence of
3-aminobenzamide in peroxynitrite-treated cells.
Moreover, poly(ADP-ribose) polymerase inhibition
by 3-aminobenzamide dose-dependently reduced
interferon-induced intercellular adhesion molecule 1
expression as well as interleukin-1b-induced interleu-
kin-8 expression. Our results indicate that peroxyni-
trite and poly(ADP-ribose) polymerase regulate
keratinocyte function and death in contact
hypersensitivity. Key words: apoptosis/in¯ammation/
interleukin-8/keratinocyte/necrosis. J Invest Dermatol
117:74±80, 2001
C
ontact hypersensitivity (CHS) is a form of delayed
type hypersensitivity caused by various lipophilic
compounds (Grabbe and Schwarz, 1998). The
sensitization phase of CHS has been the focus of
interest of dermato-immunologists for decades and it
is therefore well characterized. The elicitation phase of the response
is not well understood, however. Nitric oxide, a free radical
synthesized from L-arginine by nitric oxide synthase enzymes
(NOS), has been proposed to be a major mediator of in¯ammation
in the elicitation phase of CHS (Morita et al, 1996; Ormerod et al,
1997; Rowe et al, 1997; Ross et al, 1998). Enhanced expression of
the mRNA of inducible NOS (iNOS) has been detected in
Langerhans cells and keratinocytes in the elicitation phase of 2,4-
dinitro¯uorobenzene-induced CHS (Ross et al, 1998). In the same
model, as well as in picryl-chloride-induced CHS, pharmacologic
NOS inhibition suppressed the hypersensitivity reaction (Morita et
al, 1996; Ross et al, 1998). The question arises, however, whether
NO directly or indirectly through the formation of a more reactive
intermediate such as peroxynitrite contributes to tissue injury in
CHS.
Peroxynitrite, a cytotoxic oxidant formed in the near diffusion-
limited reaction of nitric oxide and superoxide (Beckman and
Koppenol, 1996; Groves, 1999), is an important mediator of tissue
injury in various forms of in¯ammation, shock, and ischemia-
reperfusion injury (SzaboÂ, 1996a; 1996b; Ma et al, 1997). The
cytotoxic effect of peroxynitrite is attributed to inhibition of the
mitochondrial respiratory chain, inactivation of ion channels,
initiation of lipid peroxidation, protein oxidation, DNA damage,
and interference with protein tyrosine phosphorylation (Gow et al,
1996; Kong et al, 1996; Groves, 1999). In addition, peroxynitrite
triggers an indirect suicidal pathway mediated by poly(ADP-ribose)
polymerase (PARP). PARP, a nuclear nick sensor enzyme, cleaves
NAD+ to nicotinamide and ADP-ribose and polymerizes the latter
on nuclear acceptor proteins such as histones, transcription factors,
and PARP itself (de Murcia and Menissier de Murcia, 1994).
Excessive PARP activation depletes cellular NAD+ and ATP pools
and results in necrotic cell death (Cochrane, 1991). Pharmacologic
inhibition of PARP or the PARP±/± phenotype provided remark-
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able protection in disease models of hemorrhagic shock, stroke,
myocardial ischemia, streptozotocin-induced diabetes, diabetes-
associated endothelial dysfunction, arthritis, and traumatic brain
injury, indicating that PARP activation may be involved in the
pathomechanism of these diseases (SzaboÂ and Dawson, 1998;
Liaudet et al, 2000; Soriano et al, 2001). Very limited information is
available in the literature regarding the possible role of peroxynitrite
and PARP activation in skin pathology. Nitric oxide, a parent
molecule of peroxynitrite, has been shown to be produced by
iNOS in keratinocytes, Langerhans cells, and dermal microvascular
endothelial cells (Arany et al, 1996; Qureshi et al, 1996; Hoffmann
et al, 1999). As superoxide is continously ``leaking'' from the
mitochondrial respiratory chain and is also produced by NADPH
oxidase and xanthine oxidase enzymes under in¯ammatory condi-
tions, the possibility exists that peroxynitrite is formed in the
in¯amed skin and PARP activation may also occur. Indeed,
peroxynitrite has been shown to be produced by ultraviolet-B-
irradiated keratinocytes and endothelial cells and has been impli-
cated in ultraviolet-B-induced skin in¯ammation (Deliconstantinos
et al, 1996a; 1996b; 1996c). Furthermore, nitrotyrosine, as an
indicator of in vivo peroxynitrite production, has been detected in
skin homogenates from burns, chronic ultraviolet-B exposure,
ischemia reperfusion, murine leishmaniasis, and systemic sclerosis
(Giorgio et al, 1996; Hattori et al, 1996; Cotton et al, 1999; Um et
al, 1999; Rawlingson et al, 2000).
The aim of this study was to investigate (i) whether peroxynitrite
is produced in the skin during CHS, (ii) whether DNA breakage
and PARP activation occur in CHS, (iii) whether peroxynitrite can
activate PARP in the skin, (iv) the cytostatic and cytotoxic effect of
peroxynitrite on the human keratinocyte cell line HaCaT, (v) the
role of PARP in the peroxynitrite-induced cytostasis and
cytotoxicity in HaCaT cells, and (vi) whether PARP is involved
in the cytokine-induced activation of HaCaT cells.
MATERIALS AND METHODS
Materials Unless speci®ed otherwise, all chemicals and materials listed
were purchased from Sigma-Aldrich (St. Louis, MO). 3-
Aminophenanthridinone was from the rare chemical library of Sigma-
Aldrich. Peroxynitrite was a kind gift from Dr. Harry Ischiropoulos
(University of Pennsylvania Medical Center, Philadelphia, PA).
Animals Animal experiments conform with the Guide for the Care and
Use of Laboratory Animals published by the US National Institute of
Health and the treatment protocol was approved by the Institutional
Animal Care and Use Committee. Female CD1 mice were used in the
experiments and were allowed free access to food and water.
CHS model and in vivo peroxynitrite treatment A total of 12 mice
were randomized into two groups (control group and CHS group).
Sensitization was carried out on the shaved abdominal wall by the
administration of 100 ml 2% oxazolone solubilized in acetone:olive oil
4:1 (CHS group, n = 6) or 100 ml vehicle (control group, n = 6). After
7 d, all animals were challenged by applying 20 ml 0.5% oxazolone on
each ear. After 24 h, mice were sacri®ced by CO2 and ears were
immediately removed and placed in formalin or frozen in
cryoembedding medium.
For in vivo peroxynitrite treatment, peroxynitrite was diluted in
phosphate-buffered saline (PBS, pH 11.0) and 400 nmol was smeared on
the shaved abdominal wall in a volume of 200 ml. Control mice were
treated with the vehicle (PBS, pH 11.0). After 30 min, skin was excised
and frozen in cryoembedding medium.
Immunohistochemistry The immunohistochemical procedure was
carried out basically as described previously (ViraÂg et al, 1998b) with
slight modi®cations, as follows. Paraf®n sections (5 mm) were treated
with 0.3% hydrogen peroxide for 15 min to block endogenous
peroxidase activity and then rinsed brie¯y in PBS. Non-speci®c binding
was blocked by incubating the slides for 1 h in 2% goat serum (in PBS).
To detect nitrotyrosine, rabbit polyclonal antinitrotyrosine antibody
(Upstate Biotechnology, Lake Placid, NY) was applied for 2 h in a
dilution of 1:1000 at room temperature. (Control sections were
incubated with either normal rabbit serum or with the primary antibody
in the presence of 10 mM nitrotyrosine.) Following extensive washing
(®ve 3 5 min) with PBS, immunoreactivity was detected with a
biotinylated goat antirabbit secondary antibody and the avidin±biotin-
peroxidase complex (ABC), both supplied in the Vector Elite kit (Vector
Laboratories, Burlingame, CA). Color was developed using nickel-DAB
substrate. Sections were counterstained with nuclear fast red for 2 min,
dehydrated, and mounted in Permount medium.
Detection of DNA strand breaks DNA breakage was detected with a
commercially available kit (Roche Molecular Biochemicals, Indianapolis,
IN) following the manufacturer's instructions. Dewaxed and rehydrated
sections were treated with 20 mg per ml proteinase K (in 10 mM
Tris/HCl pH 7.8) for 30 min at 37°C. DNA breaks were labeled with
terminal deoxyribonucleotide transferase (TdT) and a deoxyribo-
nucleotide mix containing ¯uorescein isothiocyanate (FITC) labeled
dUTP for 60 min at 37°C. After washing, sections were incubated with
anti-FITC peroxidase conjugate (30 min at room temperature), and
peroxidase was detected as described above for immunohistochemistry.
In situ PARP activity assay PARP activity in tissues was detected by
an in situ histochemical reaction utilizing biotinylated NAD+ as substrate
of PARP (Zhang, 1997). Cryosections were ®xed in 95% ethanol at
±20°C and then rinsed in PBS. Reaction mixture (10 mM MgCl2,
1 mM dithiothreitol, 70 mM biotinylated NAD+, in 100 mM Tris,
pH 8.0) was applied to the sections for 30 min at room temperature. A
reaction mix containing 5 mM 3-aminobenzamide (3-AB) or biotinyl-
NAD+-free reaction mix was used as control. After three washes in PBS,
incorporated biotin was detected by peroxidase-conjugated streptavidine
(Trevigen, Gaithersburg, MD). Color development, counterstaining,
and mounting were carried out exactly as described for the
immunohistochemistry.
Cell culture and peroxynitrite treatment HaCaT cells (kindly
provided by Dr. Ulrich Rodeck, Thomas Jefferson University,
Philadelphia, PA, with the permission of Professor Norbert E. Fusenig,
German Cancer Research Center, Heidelberg, Germany) were cultured
in RPMI 1640 medium supplemented with 10% fetal bovine serum,
10 mM glutamine, 10 mM HEPES, 100 U per ml penicillin, and 100 mg
per ml streptomycin. The concentration of authentic peroxynitrite was
determined spectrophotometrically by measuring absorbance at 302 nm
using an extinction coef®cient of 1670 M±1 cm±1. Peroxynitrite was
diluted in PBS (pH 11.0) and was added to the cells in 1/10 of the
volume of the cell suspension. Under these conditions addition of
peroxynitrite does not shift the pH of the medium. Control samples
were treated with PBS (pH 11.0) only. The effect of decomposed
peroxynitrite (kept in PBS pH 7.2 at 37°C for 30 min) has also been
tested in all of the assays and was found to have no effect on any
parameters measured.
Cell proliferation and cytotoxicity assays Cell proliferation was
determined with a commercially available enzyme-linked immunosorbent
assay (ELISA) kit (Amersham Pharmacia Biotechnology, Piscataway, NJ)
based on the measurement of BrDU incorporation. The assay was carried
out in 96-well tissue culture plates following the manufacturer's
instructions. Cytotoxicity was quantitated with the colorimetric MTT
test, as described previously (ViraÂg et al, 1995).
Cellular PARP activity assay PARP activity was measured as
previously described (ViraÂg et al, 1998a). Medium was removed from the
cells 20 min after peroxynitrite treatment and cells were incubated at
37°C in 0.5 ml assay buffer [56 mM Hepes pH 7.5, 28 mM KCl,
28 mM NaCl, 2 mM MgCl2, 0.01% digitonin, and 0.125 mM 3H-NAD
(0.5 mCi per ml)]. Cells were then scraped and transferred into
Eppendorf tubes. Next, 200 ml ice-cold 50% trichloroacetic acid (TCA)
was added to the samples and tubes were incubated for 4 h at 4°C.
Samples were then spun (10,000g, 10 min) and the pellets were washed
twice in ice-cold 5% TCA and solubilized overnight in 250 ml 2%
sodium dodecyl sulfate/0.1 N NaOH at 37°C. The contents of the tubes
were added to 7 ml ScintiSafe Plus scintillation liquid (Fisher Scienti®c)
and radioactivity was determined in a liquid scintillation counter (Wallac,
Gaithersburg, MD).
Measurement of caspase activation Caspase activity was measured
by the cleavage of the ¯uorogenic tetrapeptide-amino-4-
methylcoumarine conjugate (DEVD-AMC), as described previously
(ViraÂg and SzaboÂ, 1998). Cells were harvested 6 h after peroxynitrite
treatment, washed in 1 3 PBS, and then lyzed in a lysis buffer (10 mM
HEPES, 0.1% CHAPS, 5 mM dithiothreitol, 2 mM ethylenediamine
tetraacetic acid, 10 mg per ml aprotinin, 20 mg per ml leupeptin, 10 mg
per ml pepstatin A, and 1 mM phenylmethylsulfonyl ¯uoride, pH 7.25).
Cell lysates and substrates (50 mM) were combined in triplicate in the
caspase reaction buffer (100 mM HEPES, 10% sucrose, 5 mM
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dithiothreitol, 0.1% CHAPS, pH 7.25). AMC liberation was monitored
over time with a Shimadzu ¯uorimeter using 380 nm excitation and
460 nm emission wavelength.
Measurement of DNA fragmentation DNA fragmentation was
measured with a commercially available ELISA kit (Roche Molecular
Biochemicals, Indianapolis, IN) following the manufacturer's instructions,
as previously described (ViraÂg et al, 1998a). The assay is based on the
detection of histone-associated DNA fragments from the cytoplasmic
fraction of cell lysates. HaCaT cells (2 3 105) were seeded into 12-well
plates in 1000 ml culture medium and treated with different
concentrations of peroxynitrite. After 6 h incubation (37°C, 5% CO2)
cells were washed with cold PBS, scraped into 400 ml incubation buffer
(supplied with the kit), and incubated at 4°C for 60 min. Cell lysates
were then transferred to Eppendorf tubes and centrifuged (10,000g,
10 min). Supernatants were diluted 103 and measured in an ELISA
(antihistone capturing antibody, peroxidase-conjugated anti-DNA
secondary antibody, ABTS substrate). Absorbance was then measured
(405 nm) versus substrate solution as a blank using a Spectramax 250
microplate reader (Molecular Devices, Sunnyvale, CA).
Determination of intercellular adhesion molecule 1 (ICAM-1)
expression HaCaT cells were stimulated by 30 ng per ml (300 U per
ml) recombinant human interferon-g (R&D Systems, Minneapolis, MN)
for 24 h. Cells were then scraped and washed twice in ice-cold PBS.
Staining was performed on ice with FITC-conjugated monoclonal
antihuman ICAM-1 antibody (Pharmingen, San Diego, CA) and
isotype-matched monoclonal antibody (Pharmingen) as a control for 1 h.
Figure 1. Tyrosine nitration, DNA breakage,
and PARP activation in CHS. Ears were
obtained from sensitized mice 24 h after the
second challenge with oxazolone. Paraf®n-
embedded sections were used for nitrotyrosine
staining (A, B) and for the detection of DNA
breaks (C, D). PARP activity was visualized by in
situ PARP assay in frozen sections (E, F). For all
three reactions control ears from nonsensitized
mice (A, C, E) were stained in parallel with CHS
ears (B, D, F). Keratinocytes from CHS stain
positive for nitrotyrosine (B), display massive
DNA breakage (D), and show PARP activation
(F). In®ltrating cells of microabscessi are negative
for nitrotyrosine but many of them contain DNA
breaks. Insert shows negative staining of a CHS
section stained with normal rabbit serum instead
of rabbit polyclonal antinitrotyrosine antibody.
(Scale bar, 6 mm.)
Figure 2. Peroxynitrite-induced PARP
activation in the skin and in HaCaT cells.
Peroxynitrite (400 nmol in 200 ml) was applied to
the skin of mice. After 30 min, skin samples were
excised and frozen in cryoembedding medium.
Cryosections were stained by in situ PARP
enzymehistochemistry. Intense PARP activation
was found in the peroxynitrite-treated skin (B)
but not in the control (vehicle-treated) skin (A)
(scale bar, 6 mm). HaCaT cells were treated with
the indicated concentrations of peroxynitrite for
30 min and PARP activity was then determined
by 3H-NAD incorporation (C). Peroxynitrite
induced a signi®cant (**p < 0.01) PARP
activation. Pretreatment of cells with 3 mM
PARP inhibitor, 3-AB, abolished PARP
activation (##p < 0.01).
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Cells were then washed twice in ice-cold PBS and ®xed in 1%
paraformaldehyde. Samples were analyzed on a FACSCalibur ¯ow
cytometer (Becton Dickinson, San Diego, CA) and ICAM-1 expression
was determined as an increase in mean ¯uorescence intensity.
Measurement of interleukin-8 (IL-8) production HaCaT cells were
stimulated for 24 h with 20 ng per ml human recombinant IL-1b (R&D
Systems) in the presence or absence of PARP inhibitors. Supernatants
were then collected and assayed for IL-8 in a commercially available
sandwich ELISA system (R&D Systems).
Statistical analysis Results are reported as mean 6 SD of
quadruplicate samples. Experiments were repeated at least n = 3±4 times.
Student's t test was used to compare mean values. Statistical differences
were declared signi®cant for p < 0.05.
RESULTS
Tyrosine nitration in the in¯amed skin during CHS As
peroxynitrite nitrates the tyrosine residues of various proteins, in vivo
peroxinitrite production is indicated by the presence of
nitrotyrosine-containing proteins in the tissues. Nitrotyrosine
could be detected by immunohistochemistry in the sections of
ears from CHS mice but not from control (nonsensitized) ones
(Fig 1). Tyrosine nitration of keratinocytes was most intense in the
vicinity of in¯ammatory foci (microabscessi). Somewhat
surprisingly, only a small number of in®ltrating granulocytes
displayed immunoreactivity for nitrotyrosine. Nitrotyrosine was
not detectable in control nonsensitized skin (Fig 1).
Increased DNA breakage during CHS-induced skin
in¯ammation As the formation of nitrotyrosine is most
probably caused by peroxynitrite, which is a potent inducer of
DNA breakage, we performed TUNEL staining on skin samples
from CHS and control nonsensitized animals (Fig 1). Only faint
positivity could be detected in some scattered cells in control skin
tissues. In contrast, CHS-induced dermatitis resulted in a massive
increase of TUNEL-positive cells both in the in®ltrating cells of
microabscessi and in keratinocytes (Fig 1). It is worthwhile noting
here that the TUNEL assay is widely used to detect apoptotic cells;
however, what it detects are free 3¢-OH ends in DNA, which can
be caused by either single or double strand breaks. In fact, the
TUNEL assay has been used to detect single strand breakage in
several systems (Didier et al, 1996; Ahmadi and Ong, 1999; Jung et
al, 2000; Mihm et al, 2000; Shen and Ong, 2000). Moreover, it has
also been reported recently that proteinase K treatment (applied in
Figure 3. Antiproliferative and cytotoxic effect of peroxynitrite
in HaCaT cells. Proliferation (left panel) and viability (right panel) of
HaCaT cells have been determined after treatment of cells with the
indicated concentrations of peroxynitrite. Treatment was carried out in
the presence or absence of 3-AB (3 mM). Asterisks indicate signi®cant
(*p < 0.05, **p < 0.01) protection provided by the PARP inhibitor.
Figure 4. Peroxynitrite-induced caspase
activation and DNA fragmentation in
HaCaT cells. HaCaT cells were treated with
increasing concentrations of peroxynitrite in the
presence or absence of 3 mM 3-AB. After 6 h,
caspase activity (left panel) and DNA fragmentation
were determined. Asterisks indicate signi®cantly
(*p < 0.05, **p < 0.01) elevated caspase activity
or DNA fragmentation. Hash marks indicate
signi®cant difference between 3-AB-treated and
untreated cells.
Figure 5. Effect of PARP inhibition on
ICAM-1 expression and IL-8 production of
immune-stimulated HaCaT cells. (A)
ICAM-1 expression; (B) IL-8 production.
HaCaT cells were stimulated for 24 h with
30 ng per ml human recombinant interferon-g
to induce ICAM-1 expression or with human
recombinant IL-1b to induce IL-8 secretion.
Induction was carried out in the presence or
absence of 3-AB. 3-AB (3 mM) caused
signi®cant (*p < 0.05, **p < 0.01) inhibition
of both ICAM-1 expression and IL-8
secretion.
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TUNEL kits) enhances the detection of single strand breaks in non-
apoptotic cells (Gal et al, 2000). In our system, we believe that
DNA single strand breaks are responsible for the majority of
TUNEL positivity, as most TUNEL-positive nuclei do not show
apoptotic morphology. Moreover, the vast majority of TUNEL-
positive cells stain negative for p85 (a fragment of PARP generated
by caspase-mediated cleavage of the 116 kDa enzyme during
apoptosis) (not shown), indicating that no caspase activation occurs.
Moreover, we found that almost 100% of keratinocytes
surrounding the in¯ammatory foci are TUNEL positive, which
would be an improbably high apoptotic percentage.
PARP activation in CHS We detected PARP activation in
CHS by in situ PARP activity assay. PARP activity was not
detectable in control sections (Fig 1E). In CHS, we found strong
staining in keratinocytes and also in various dermal cells (Fig 1F).
When the reaction was carried out in the presence of 5 mM 3-AB,
no staining could be detected (not shown).
Peroxynitrite induces PARP activation in the skin and in
HaCaT cells As peroxynitrite has been shown to cause DNA
single strand breaks in human keratinocytes (Spencer et al,
1996), we investigated whether poly(ADP-ribose) polymerase, a
nuclear nick sensor enzyme, becomes activated in peroxynitrite-
treated keratinocytes. To prove that peroxynitrite can activate
PARP in the skin, we applied 400 nmol peroxynitrite on the
skin of mice for 30 min. Control animals were treated with
vehicle (PBS, pH 11.0). We found intense PARP activation in
the peroxynitrite-treated skin but not in control skin, as
detected by in situ PARP activity assay (Fig 2A, B). PARP
activation was most intense in keratinocytes; however, some
dermal cells also stained positive. The presence of the PARP
inhibitor 3-AB (5 mM) in the reaction mixture abolished the
staining.
We also investigated the cellular effects of peroxynitrite in a
human keratinocyte-derived cell line (HaCaT). Peroxynitrite
induced a concentration-dependent PARP activation (Fig 2C),
which was completely blocked by the PARP inhibitor 3-AB.
Antiproliferative and cytotoxic effect of peroxynitrite in
HaCaT cells Peroxynitrite caused a dose-dependent inhibition
of cell proliferation (Fig 3A) and also caused cytotoxicity (Fig 3B).
PARP is not likely to be involved in proliferation inhibition caused
by the lowest concentrations of peroxynitrite, as 3-AB had no
effect on this parameter. At higher concentrations, the
antiproliferative effect of peroxynitrite was in part mediated by
PARP activation, as indicated by the signi®cant cytoprotective
effect of 3-AB. 3-AB also provided signi®cant protection against
peroxynitrite-induced cytotoxicity (Fig 3B). Similar results were
obtained with another PARP inhibitor, 3-amino-
phenanthridinone (5 mM) (not shown).
Peroxynitrite-induced caspase activation and DNA
fragmentation in HaCaT cells Peroxynitrite has been
reported to cause apoptosis in various cell types including
thymocytes, HL-60 cells, and PC12 cells (Estevez et al, 1995; Lin
et al, 1995; ViraÂg and SzaboÂ, 1998; ViraÂg et al, 1998a). Here we
show that peroxynitrite also causes apoptosis in HaCaT cells, as
indicated by increased caspase-3-like activity (Fig 4A) and DNA
fragmentation (Fig 4B). With other cell types we have previously
shown that pharmacologic PARP inhibition or the absence of
PARP (in PARP±/± cells) shifts the oxidant-induced necrotic cell
death toward apoptosis and toward the normal phenotype (ViraÂg et
al, 1998a; 1998c). The increase in DNA fragmentation is usually
more pronounced than the increase in caspase activation, indicating
that DNA fragmentation is more sensitive to the consequences
(e.g., ATP depletion) of PARP activation. In peroxynitrite-treated
HaCaT cells, in the presence of 3-AB we have detected a
moderately increased DNA fragmentation but virtually unchanged
caspase activity (Fig 4). 3-AB (2±16 mM) alone, however, did not
cause caspase activation or DNA fragmentation (data not shown).
Involvement of PARP in the regulation of ICAM-1
expression and IL-8 production Human recombinant
interferon-g (30 ng per ml) induced a ninefold increase in the
cell surface expression of ICAM-1. Interferon-g-induced ICAM-1
expression was dose-dependently inhibited by 3-AB. The highest
concentration (4 mM) of the PARP inhibitor caused a 50%
reduction in the expression of ICAM-1. Similar results were
obtained with another PARP inhibitor, 3-amino-
phenanthridinone (5 mM) (not shown).
In serum-containing media, HaCaT cells are known to spon-
taneously produce IL-8 (Stein et al, 1997). We found that IL-1b
increased the production of IL-8 by HaCaT cells. Both the basal
and the IL-1b-induced IL-8 production were inhibited by 3-AB
(4 mM), indicating a possible involvement of PARP in the
regulation of IL-8 expression.
DISCUSSION
Here we provide evidence that intense tyrosine nitration occurs in
the epidermis during CHS. Detection of nitrotyrosine in tissues is
regarded as an indicator of in vivo peroxynitrite production
(Beckman and Koppenol, 1996). Although microabscessi in the
skin contained a large number of neutrophil granulocytes, the vast
majority of these cells did not stain for nitrotyrosine. In contrast to
in®ltrating cells, keratinocytes showed the most intense staining for
nitrotyrosine, thus representing the prime targets of peroxynitrite in
the skin during CHS. The most likely scenario for increased
tyrosine nitration is that in¯ammatory cytokines induce the
upregulation of iNOS synthase and overproduction of superoxide.
iNOS-derived NO and superoxide, in turn, react to form
peroxynitrite, which nitrates tyrosine. Other mechanisms of
in vitro tyrosine nitrations, most notably the one mediated by
myeloperoxidase, have also been described (Sampson et al, 1998);
however, the in vivo signi®cance of these alternative tyrosine
nitration pathways remains to be proven. Our ®nding that
in¯ammatory cells in microabscessi were negative for nitrotyrosine
makes it unlikely that myeloperoxidase-mediated tyrosine nitration
occurs in our model.
We have also shown that, in CHS, intense DNA breakage occurs
in keratinocytes as well as in in®ltrating cells. Based on the lack of
apoptotic morphology, lack of caspase activation, and the unani-
mous staining of keratinocytes surrounding the in¯ammatory foci,
we propose that single stranded DNA breakage occurs in the
keratinocytes during CHS. In fact, peroxynitrite has been shown to
cause DNA damage in various cell types including human
keratinocytes (Spencer et al, 1996; SzaboÂ, 1996b). In light of the
proapoptotic effect of peroxynitrite, however, it cannot be
excluded that a fraction of TUNEL-positive cells are apoptotic.
We have investigated the cellular effects of peroxynitrite in
HaCaT cells with special regard to the role played by PARP. Nitric
oxide, one of the parent molecules of peroxynitrite, has been
shown to enhance the proliferation of HaCaT cells (Stallmeyer et al,
1999). Peroxynitrite at lower concentrations was antiproliferative,
further emphasizing the differences in the cellular effects of NO and
peroxynitrite. The differences in the chemistry, reactivity, and
target molecule spectrum may account for the often divergent
cellular effects of NO and peroxynitrite. At higher concentrations
peroxynitrite induced cytotoxicity. Similarly to our previous
observations (SzaboÂ et al, 1998; ViraÂg et al, 1998a; 1998c) we
found cytoprotection by PARP inhibitors against peroxynitrite-
induced cytotoxicity in HaCaT cells. The cytoprotection provided
by 3-AB is not related to inhibition of apoptosis, as caspase
activation and DNA fragmentation were not reduced. On the
contrary, 3-AB caused a moderate increase in peroxynitrite-
induced apoptotic DNA fragmentation. This is not due to the
cytotoxic effect of 3-AB, as 3-AB alone (2, 4, 8, 16 mM) caused
neither cytotoxicity nor caspase activation or DNA fragmentation
(data not shown). The increased output of apoptotic parameters in
3-AB-treated and oxidatively stressed cells is in line with our
previous ®ndings as well as reports from other laboratories showing
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a diversion by PARP inhibitors of oxidant-induced necrosis toward
apoptosis (ViraÂg et al, 1998a; Filipovic et al, 1999; Ha and Snyder,
1999). Switching the mode of cell death from necrosis to apoptosis
may be anti-in¯ammatory in vivo, as it prevents the leakage of the
proin¯amatory cell content into the tissues. In oxidatively injured
cells, the mechanism of the necrosis to apoptosis switch in the
presence of PARP inhibitors is probably the preservation of NAD+
and ATP pools that would be depleted by PARP activation. In
HaCaT cells, however, the increase in DNA fragmentation in the
presence of 3-AB is less than in other cell types. This is likely to be
due to differences in the metabolism of different cell types.
The question arises, however, whether PARP inhibitors may
have therapeutic potential in CHS. We believe that PARP
inhibition may prevent oxidant-induced cell dysfunction and
cytotoxicity, by preserving cellular energy stores. PARP inhibitors
may also have bene®cial effects in other human skin diseases such as
Stevens±Johnson syndome or toxic epidermal necrolysis where
keratinocyte necrosis is accompanied by iNOS expression (Lerner
et al, 2000); therefore the NO±peroxynitrite±PARP activation±
necrosis pathway may be involved in the pathogenesis of these
diseases.
Another important mechanism by which PARP may be
involved in CHS and other in¯ammatory dermatoses is the
regulation of keratinocyte activation. Upon cytokine stimulation,
keratinocytes are known to produce numerous humoral factors,
among them chemokines such as IL-8. IL-8 is responsible for the
recruitment of neutrophil granulocytes into the sites of in¯amma-
tion, so that inhibition of IL-8 production by PARP inhibitors may
reduce in¯ammation. Upregulation of adhesion molecules is also
important in the regulation of cellular traf®cking during in¯am-
mation; thus the inhibitory effect of PARP inhibition on ICAM-1
expression might be anti-in¯ammatory (Zingarelli et al, 1998). The
transcription factor NFkB is a key regulator of the expression of
in¯ammatory proteins (Baeuerle and Baltimore, 1996), including
chemokines and adhesion molecules. PARP has been shown to
enhance the effect of NFkB (Oliver et al, 1999), indicating that
inhibition of NFkB activation by PARP inhibitors may be
responsible for the reduced IL-8 production and ICAM-1 expres-
sion in 3-AB-treated HaCaT cells.
CONCLUSIONS
(i) CHS leads to peroxynitrite production, DNA breakage, and
PARP activation in keratinocytes. (ii) Peroxynitrite activates PARP
in the skin. (iii) Peroxynitrite causes apoptosis characterized by
caspase activation and DNA fragmentation in HaCaT cells. (iv) At
higher concentrations, peroxynitrite causes necrosis in HaCaT cells.
(v) Peroxynitrite activates PARP in HaCaT cells. (vi) PARP plays a
role in the cytokine-induced activation of keratinocytes.
Our ®ndings provide rationale for experimental therapies of
CHS and possibly other in¯ammatory dermatoses by targeting
peroxynitrite or PARP.
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